| Literature DB >> 25890385 |
Yun Feng1, Yu Ding2, Juan Liu3, Ye Tian4, Yanzhou Yang5, Shuluan Guan6, Cheng Zhang7.
Abstract
BACKGROUND: Polyunsaturated fatty acids (PUFAs) are necessary for the body's metabolism, growth and development. Although PUFAs play an important role in the regulation of reproduction, their role in testis development in the rooster is unknown. The present study was conducted to investigate the effects of omega-3/omega-6 (n-3/n-6, PUFAs) ratios on reproductive performance in young breeder roosters. Plasma levels of reproductive hormones, testis development, and reproductive hormone receptor and StAR mRNA expression were also assessed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25890385 PMCID: PMC4396019 DOI: 10.1186/s12917-015-0394-9
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Fatty acid composition of soybean oil and linseed oil (%)
|
|
|
|
|---|---|---|
| C14:0 | 0.11 | 0.04 |
| C15:0 | 0.02 | 0.02 |
| C16:0 | 11.86 | 5.87 |
| C16:1 | 0.14 | 0.06 |
| C18:0 | 4.74 | 4.49 |
| C18:1 | 21.60 | 22.30 |
| C18:3 n-6 | 52.58 | 16.67 |
| C18:3 n-3 | 7.65 | 49.85 |
| C20:0 | 0.25 | 0.12 |
| C20:1 | 0.19 | 0.16 |
| C20:3 n-6 | — | — |
| C20:3 n-3 | — | 0.06 |
| C22:0 | 0.36 | 0.10 |
| C22:1 | 0.11 | 0.06 |
| C24:0 | 0.07 | 0.03 |
| Others | 0.30 | 0.15 |
| Total | 100.00 | 100.00 |
| n-3 PUFAs | 7.65 | 49.91 |
| n-6 PUFAs | 52.58 | 16.67 |
| n-3/n-6 | 1:7.34 | 1:0.33 |
The values were determined by feed analysis test.
Fatty acid composition of diets (%)
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| C14:0 | 0.05 | 0.01 | 0.02 | 0.02 | 0.02 |
| C15:0 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| C15:1 | 0.02 | — | — | — | — |
| C16:0 | 14.48 | 14.67 | 13.74 | 13.03 | 13.15 |
| C16:1 | 0.14 | 0.13 | 0.14 | 0.13 | 0.14 |
| C18:0 | 3.12 | 3.34 | 2.99 | 3.35 | 3.26 |
| C18:1 | 23.58 | 25.63 | 23.91 | 23.29 | 24.13 |
| C18:2 n-6 | 53.93 | 48.53 | 48.19 | 47.40 | 40.38 |
| C18:3 n-3 | 2.93 | 6.20 | 9.58 | 11.42 | 17.47 |
| C20:0 | 0.43 | 0.44 | 0.38 | 0.37 | 0.37 |
| C20:1 | 0.28 | 0.29 | 0.28 | 0.31 | 0.32 |
| C20:3 n-6 | 0.04 | 0.04 | 0.06 | 0.09 | 0.14 |
| C20:3 n-3 | — | — | — | — | — |
| C22:0 | 0.27 | 0.24 | 0.20 | 0.19 | 0.18 |
| C23:0 | 0.14 | 0.06 | 0.05 | 0.04 | 0.03 |
| C22:1 | 0.15 | 0.10 | 0.18 | 0.14 | 0.16 |
| C24:0 | — | — | — | — | — |
| Others | 0.42 | 0.29 | 0.25 | 0.19 | 0.22 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| n-3 PUFAs | 53.97 | 48.57 | 48.25 | 47.49 | 40.52 |
| n-6 PUFAs | 2.93 | 6.20 | 9.58 | 11.42 | 17.47 |
| n-3/n-6 | 1:18.39 | 1:7.84 | 1:5.04 | 1:4.15 | 1:2.32 |
The values were determined by feed analysis test.
Effects of different ratios of N-3/N-6 PUFAs on the testes index
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 21d | 1 | 1.2157 ± 0.0779a | 0.2463 ± 0.0289 | 0.2610 ± 0.0291 | 0.5740 ± 0.1245 | 0.4185 ± 0.0432 |
| 2 | 1.3115 ± 0.0542a | 0.2883 ± 0.0339 | 0.3030 ± 0.0325 | 0.4580 ± 0.1344 | 0.4483 ± 0.0315 | |
| 3 | 1.4752 ± 0.0139b | 0.3117 ± 0.0314 | 0.3223 ± 0.0364 | 0.6307 ± 0.0707 | 0.4304 ± 0.0483 | |
| 4 | 1.3922 ± 0.0161b | 0.3683 ± 0.0352 | 0.3807 ± 0.0349 | 0.9063 ± 0.1492 | 0.5382 ± 0.0508 | |
| 5 | 1.3055 ± 0.0610a | 0.3637 ± 0.0562 | 0.3807 ± 0.0544 | 0.7443 ± 0.1107 | 0.5648 ± 0.0622 | |
| 35d | 1 | 1.5703 ± 0.0504 | 0.8743 ± 0.0239 | 0.8904 ± 0.0211 | 1.7647 ± 0.0451 | 1.1276 ± 0.0610 |
| 2 | 1.5948 ± 0.0431 | 0.8890 ± 0.0191 | 0.9103 ± 0.0136 | 1.7993 ± 0.0321 | 1.1294 ± 0.0298 | |
| 3 | 1.5680 ± 0.0264 | 0.8882 ± 0.0078 | 0.9025 ± 0.0134 | 1.7907 ± 0.0208 | 1.1428 ± 0.02678 | |
| 4 | 1.6027 ± 0.0440 | 0.9050 ± 0.0128 | 0.9317 ± 0.0093 | 1.8367 ± 0.0218 | 1.14789 ± 0.0371 | |
| 5 | 1.5797 ± 0.0170 | 0.8923 ± 0.0482 | 0.9167 ± 0.0673 | 1.8090 ± 0.0113 | 1.1423 ± 0.0058 |
Testis index = testis weight (g)/body weight (kg).
In the same column, values with different small letter superscripts mean significant difference (P < 0.05).
Figure 1Effects of different ratio of n-3/n-6 on morphology of chicken testis. A, B, C, D and E were the morphology of chicken testis on day 21, and F, G, H, I and J were the the morphology of chicken testis on day 35 for treatment 1–5. Magnification, × 400; Bar = 50 μm.
Effects of different ratios of N-3/N-6 PUFAs on the serum hormone levels
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 21d | 1 | 114.8510 ± 3.6500a | 2.1117 ± 0.0816b | 5.3316 ± 0.0935 | 9.4830 ± 0.2194a |
| 2 | 117.8113 ± 1.9410a | 2.0503 ± 0.0245ab | 5.3893 ± 0.1400 | 9.5000 ± 0.1830ab | |
| 3 | 117.9606 ± 4.5833a | 2.1187 ± 0.2904b | 5.2857 ± 0.1560 | 9.5286 ± 0.5078ab | |
| 4 | 128.3990 ± 4.2219b | 2.3397 ± 0.1090b | 5.5743 ± 0.2446 | 10.6810 ± 0.3215b | |
| 5 | 118.7643 ± 5.0145a | 1.6170 ± 0.0758a | 5.3740 ± 0.1878 | 9.4426 ± 0.1897ab | |
| 35d | 1 | 118.0626 ± 5.9451a | 2.2897 ± 0.1448a | 3.8223 ± 0.0789a | 20.9670 ± 0.2361a |
| 2 | 124.7476 ± 1.7489a | 2.8570 ± 0.1251a | 4.2557 ± 0.1354a | 20.8390 ± 0.4256a | |
| 3 | 120.1923 ± 3.4892a | 2.7343 ± 0.1044a | 3.7997 ± 0.0837a | 21.3133 ± 0.8362ab | |
| 4 | 136.6667 ± 3.0792b | 3.4170 ± 0.1306b | 4.6900 ± 0.1718b | 23.6027 ± 0.3857b | |
| 5 | 122.5713 ± 2.0841a | 2.7203 ± 0.1524a | 4.3910 ± 0.3484a | 20.2320 ± 1.3243a |
In the same column, values with different small letter superscripts mean significant difference (P < 0.05).
Figure 2The mRNA relative expression of GnRHR, LHR and FSHR in chicken testis. The testis were collected for mRNA (real-time PCR) analysis. The mRNA abundance were normalized by β-actin. (A) Although the different treatments had no significant influence on GnRH content on day 21, the response was significantly up-regulated by the presence of n3/n6 (treatment 3, 4 and 5) on day 35 (***P < 0.001). (B) Treatment 2, 4 and 5 significantly increased FSHR mRNA compared with others treatments on day 21 (+++P < 0.001). (C) Diet with different ratios of n3/n6 PUFAs (treatment 2–5) significantly increased LHR mRNA level on day 21 (+++P < 0.001). The effect of PUFAs was decreased with the duration of treatment on day 35. (D) Although PUFAs had no significant effect on StAR content on day 21, the treatment 2–5 dramatically increased StAR mRNA level (**P < 0.01; ***P < 0.001). + indicates significant difference among treatments on day 21. * indicates significant difference among treatments on day 35.